Related Experiment Videos
Economic evaluation using mathematical models: the case of misoprostol prophylaxis
1Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA.
The Journal of Rheumatology
|July 1, 1995
Summary
Economic analysis using misoprostol prophylaxis shows cost-effectiveness varies. Incorporating quality of life measures is crucial for accurate health economic evaluations.
Area of Science:
- Health Economics
- Pharmacoeconomics
- Mathematical Modeling in Healthcare
Background:
- Economic evaluations are vital for healthcare decision-making.
- Mathematical models are increasingly used to assess the value of medical interventions.
- Misoprostol prophylaxis serves as a case study for applying these methods.
Purpose of the Study:
- To describe methods for economic analyses using mathematical models.
- To evaluate the cost-effectiveness and cost-utility of misoprostol prophylaxis.
- To highlight the importance of health-related quality of life in economic assessments.
Main Methods:
- Decision analysis
- Cost-effectiveness analysis (CEA)
- Cost-utility analysis (CUA)
- Sensitivity analysis (one-way, multi-way, probabilistic)
- Quality-adjusted life year (QALY) estimation
Main Results:
- Misoprostol prophylaxis cost an additional $650 per ulcer prevented compared to no prophylaxis.
- Cost-utility analysis indicated modest additional costs with no significant quality of life benefits on average.
- Prophylaxis may be cost-saving in high-risk patient groups.
- Sensitivity analysis showed variable outcomes, with a best-case incremental cost-effectiveness ratio of $9333 per QALY gained.
Conclusions:
- Economic evaluation of misoprostol prophylaxis reveals nuanced cost-effectiveness.
- Health-related quality of life measures are essential for comprehensive economic evaluations.
- Targeting high-risk groups may optimize the value of prophylactic interventions.